way-257027
Small moleculeexperimental
Clinical trial activity
3 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Feb 1, 2007 (NCT00427544)
Timeline
2000s
- Jan 1, 2007
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Progesterone receptorANTAGONIST
PGR antagonist
Chemistry & pharmacology
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL3545239 ↗
Also known as
- pf-05019702
- pra-027
- pra-027
- pra-027
- way-257027
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00543790 | Phase 1 | Nov 1, 2007 | Pfizer |
| NCT00444704 | Phase 1 | Mar 1, 2007 | Pfizer, Wyeth |
| NCT00427544 | Phase 1 | Feb 1, 2007 | Pfizer, Wyeth |
Showing 3 of 3 trials
Page 1 / 1